(CBS) – A new vaccine could soon allow people suffering from celiac disease disease to eat gluten safely
The vaccine, NexVax2, uses the body itself immune system for the treatment of celiac disease.
researchers we believe that if the vaccine is administered in small quantities at the beginning and the dosage is gradually increased, those suffering from celiac disease will develop resistance to the proteins harmful in the gluten without negative effects.
Those with celiac disease should still follow a gluten-free diet.
In 2017, the Massachusetts-based company, ImmusanT, received $ 40 million in funding to further finance search in NexVax2.
A year later, the first patient in a clinical trial received the vaccine and showed signs of progress.
This first step shows promising signals for the launch of the phase 2 clinical trial, which is called RESET CeD.
The RESET CeD study is designed to determine the effectiveness of the vaccine and whether the benefits outweigh the risks.
ImmusanT is finally trying to develop a vaccine that would eliminate the need for a gluten-free diet.
Researchers expect it will take at least five years before a drug is available to patients, but they say research on celiac disease has accelerated.
CORRELATED: Girl with celiac disease writes book so the condition is & # 39; best understood & # 39;